The company launched in September 2022 with seed funding from Cumulus Oncology, a Scottish biotech creation studio, and announced a partnership with the Lead Discovery Center in Dortmund, Germany.

The financing will be used to expand and develop Nodus’ portfolio of first-in-class and best-in-class assets.